Amir Nashat is managing partner at
Polaris Venture Partners, and currently serves on the boards of several
biotechnology companies, including AgBiome, Fate Therapeutics, Selecta
Biosciences, BIND Therapeutics and aTyr Pharma. His doctoral research focused
on information flow through neurons, neural implants and neural tissue
engineering. Amir holds a BS and MS in materials science and mechanical engineering
from the University of California, Berkeley, as well as a PhD in chemical engineering
from the Massachusetts Institute of Technology.